Identification of a Novel Inhibitor against Middle East Respiratory Syndrome Coronavirus

The Middle East respiratory syndrome coronavirus (MERS-CoV) was first isolated in 2012, and circulated worldwide with high mortality. The continual outbreaks of MERS-CoV highlight the importance of developing antiviral therapeutics. Here, we rationally designed a novel fusion inhibitor named MERS-fi...

Celý popis

Podrobná bibliografie

Hlavní autoři:	Yaping Sun, Huaidong Zhang, Jian Shi, Zhe Zhang, Rui Gong
Médium:	Artigo
Jazyk:	Inglês
Vydáno:	MDPI AG 2017-09-01
Edice:	Viruses
Témata:	MERS-CoV fusion inhibitor six-helix bundle heptad repeat five-helix bundle
On-line přístup:	https://www.mdpi.com/1999-4915/9/9/255
Tagy:	Přidat tag Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!